HEADER OXIDOREDUCTASE 15-MAR-16 5FZO TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JMJD1C COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROBABLE JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROT COMPND 3 EIN 2C; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: JUMONJI DOMAIN, UNP RESIDUES 2157-2500; COMPND 6 SYNONYM: JUMONJI DOMAIN-CONTAINING PROTEIN 1C, THYROID RECEPTOR- COMPND 7 INTERACTING PROTEIN 8, TR-INTERACTING PROTEIN 8, TRIP-8; COMPND 8 EC: 1.14.11.-; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROBABLE JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROT COMPND 12 EIN 2C; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: JUMONJI DOMAIN, UNP RESIDUES 2157-2500; COMPND 15 SYNONYM: JUMONJI DOMAIN-CONTAINING PROTEIN 1C, THYROID RECEPTOR- COMPND 16 INTERACTING PROTEIN 8, TR-INTERACTING PROTEIN 8, TRIP-8; COMPND 17 EC: 1.14.11.-; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R3-PRARE2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-CTHF; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VARIANT: R3-PRARE2; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PNIC-CTHF KEYWDS OXIDOREDUCTASE, JMJD1C EXPDTA X-RAY DIFFRACTION AUTHOR R.NOWAK,R.TALON,T.KROJER,S.GOUBIN,M.MCDONOUGH,M.FAIRHEAD,U.OPPERMANN, AUTHOR 2 C.JOHANSSON REVDAT 3 10-JAN-24 5FZO 1 REMARK LINK REVDAT 2 06-APR-16 5FZO 1 AUTHOR REVDAT 1 30-MAR-16 5FZO 0 JRNL AUTH R.NOWAK,S.GOUBIN,M.MCDONOUGH,M.FAIRHEAD,U.OPPERMANN, JRNL AUTH 2 C.JOHANSSON JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JMJD1C JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 72668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3626 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 55.4852 - 5.4494 0.99 2909 163 0.1792 0.1960 REMARK 3 2 5.4494 - 4.3259 1.00 2780 142 0.1450 0.1516 REMARK 3 3 4.3259 - 3.7792 1.00 2706 138 0.1519 0.1990 REMARK 3 4 3.7792 - 3.4337 1.00 2745 133 0.1578 0.1978 REMARK 3 5 3.4337 - 3.1876 1.00 2699 144 0.1763 0.2547 REMARK 3 6 3.1876 - 2.9997 1.00 2666 144 0.1849 0.2138 REMARK 3 7 2.9997 - 2.8495 1.00 2703 136 0.1856 0.2364 REMARK 3 8 2.8495 - 2.7255 0.99 2656 139 0.1919 0.2341 REMARK 3 9 2.7255 - 2.6205 0.99 2637 154 0.1928 0.2495 REMARK 3 10 2.6205 - 2.5301 1.00 2668 143 0.1915 0.2311 REMARK 3 11 2.5301 - 2.4510 0.99 2650 139 0.2053 0.2564 REMARK 3 12 2.4510 - 2.3809 0.99 2629 144 0.2085 0.2673 REMARK 3 13 2.3809 - 2.3183 0.99 2642 155 0.2134 0.2560 REMARK 3 14 2.3183 - 2.2617 0.99 2588 139 0.2178 0.2689 REMARK 3 15 2.2617 - 2.2103 0.98 2661 121 0.2304 0.2626 REMARK 3 16 2.2103 - 2.1632 1.00 2616 157 0.2446 0.2822 REMARK 3 17 2.1632 - 2.1200 0.98 2601 158 0.2499 0.2993 REMARK 3 18 2.1200 - 2.0800 1.00 2611 146 0.2586 0.2883 REMARK 3 19 2.0800 - 2.0428 0.97 2555 130 0.2641 0.3209 REMARK 3 20 2.0428 - 2.0082 0.99 2678 133 0.2729 0.2602 REMARK 3 21 2.0082 - 1.9758 1.00 2623 125 0.2698 0.3276 REMARK 3 22 1.9758 - 1.9454 0.96 2562 132 0.2656 0.2882 REMARK 3 23 1.9454 - 1.9168 0.99 2658 127 0.2893 0.3139 REMARK 3 24 1.9168 - 1.8898 1.00 2608 124 0.2930 0.3814 REMARK 3 25 1.8898 - 1.8642 0.96 2573 125 0.3025 0.3265 REMARK 3 26 1.8642 - 1.8400 0.99 2618 135 0.3247 0.3579 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.84 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5652 REMARK 3 ANGLE : 1.145 7697 REMARK 3 CHIRALITY : 0.050 841 REMARK 3 PLANARITY : 0.006 994 REMARK 3 DIHEDRAL : 13.435 2042 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CYSTEINE 2317 IN CHAIN A AND B IS REMARK 3 MODIFIED TO SULFENIC ACID (CSD). REMARK 4 REMARK 4 5FZO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1290066477. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96859 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72743 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.840 REMARK 200 RESOLUTION RANGE LOW (A) : 55.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: DIMPLE REMARK 200 STARTING MODEL: 2YPD REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350 -- 10% ETHYLENE GLYCOL -- REMARK 280 0.1M BIS-TRIS-PROPANE PH 8.5 -- 0.2M POTASSIUM CITRATE TRIBASIC REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.46000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.65500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.46000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 82.65500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A3026 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 2251 REMARK 465 LYS A 2252 REMARK 465 SER A 2253 REMARK 465 GLY A 2254 REMARK 465 LEU A 2499 REMARK 465 LEU A 2500 REMARK 465 ALA A 2501 REMARK 465 GLU A 2502 REMARK 465 ASN A 2503 REMARK 465 LEU A 2504 REMARK 465 TYR A 2505 REMARK 465 PHE A 2506 REMARK 465 GLN A 2507 REMARK 465 ASN B 2251 REMARK 465 LYS B 2252 REMARK 465 SER B 2253 REMARK 465 GLY B 2254 REMARK 465 LEU B 2499 REMARK 465 LEU B 2500 REMARK 465 ALA B 2501 REMARK 465 GLU B 2502 REMARK 465 ASN B 2503 REMARK 465 LEU B 2504 REMARK 465 TYR B 2505 REMARK 465 PHE B 2506 REMARK 465 GLN B 2507 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A2165 CG CD CE NZ REMARK 470 GLU A2209 CG CD OE1 OE2 REMARK 470 GLN A2219 CG CD OE1 NE2 REMARK 470 LYS A2250 CG CD CE NZ REMARK 470 GLU A2255 CG CD OE1 OE2 REMARK 470 LYS A2378 CD CE NZ REMARK 470 LYS A2381 CG CD CE NZ REMARK 470 LYS A2411 CG CD CE NZ REMARK 470 GLU A2420 CG CD OE1 OE2 REMARK 470 ARG A2425 CG CD NE CZ NH1 NH2 REMARK 470 GLN A2495 CD OE1 NE2 REMARK 470 ARG A2498 CG CD NE CZ NH1 NH2 REMARK 470 LYS B2165 CG CD CE NZ REMARK 470 LYS B2183 CG CD CE NZ REMARK 470 LYS B2187 CD CE NZ REMARK 470 GLU B2209 CG CD OE1 OE2 REMARK 470 ASP B2217 CG OD1 OD2 REMARK 470 HIS B2218 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B2250 CG CD CE NZ REMARK 470 GLU B2255 CG CD OE1 OE2 REMARK 470 LEU B2312 CG CD1 CD2 REMARK 470 LYS B2365 CE NZ REMARK 470 LYS B2366 CD CE NZ REMARK 470 LYS B2378 CD CE NZ REMARK 470 LYS B2381 CG CD CE NZ REMARK 470 SER B2383 OG REMARK 470 LYS B2397 CE NZ REMARK 470 LYS B2401 CG CD CE NZ REMARK 470 LYS B2408 CG CD CE NZ REMARK 470 LYS B2411 CG CD CE NZ REMARK 470 GLN B2413 CG CD OE1 NE2 REMARK 470 LEU B2415 CG CD1 CD2 REMARK 470 GLU B2416 CG CD OE1 OE2 REMARK 470 GLU B2420 CG CD OE1 OE2 REMARK 470 ARG B2446 CG CD NE CZ NH1 NH2 REMARK 470 GLN B2495 CG CD OE1 NE2 REMARK 470 ARG B2498 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 3185 O HOH B 3199 2.04 REMARK 500 O HOH A 3283 O HOH A 3284 2.08 REMARK 500 OE2 GLU A 2369 O HOH A 3222 2.11 REMARK 500 O HOH B 3084 O HOH B 3095 2.11 REMARK 500 OD1 ASN B 2344 O HOH B 3143 2.11 REMARK 500 O HOH A 3263 O HOH A 3264 2.12 REMARK 500 O HOH A 3013 O HOH A 3143 2.13 REMARK 500 O HOH A 3144 O HOH A 3145 2.14 REMARK 500 OD2 CSD B 2317 O HOH B 3126 2.14 REMARK 500 OD2 CSD A 2317 O HOH A 3179 2.16 REMARK 500 OE2 GLU B 2368 O HOH B 3161 2.16 REMARK 500 O HOH A 3155 O HOH A 3161 2.17 REMARK 500 O HOH A 3063 O HOH A 3064 2.18 REMARK 500 O HOH B 3040 O HOH B 3185 2.18 REMARK 500 O HOH A 3005 O HOH A 3051 2.18 REMARK 500 O HOH A 3272 O HOH A 3284 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B2265 C - N - CA ANGL. DEV. = -11.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A2415 106.63 -59.50 REMARK 500 PRO B2265 153.33 -42.36 REMARK 500 PRO B2310 96.66 -67.47 REMARK 500 ASP B2311 -107.03 47.47 REMARK 500 LEU B2312 -1.77 77.03 REMARK 500 GLU B2420 49.04 -82.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP B 2264 PRO B 2265 -108.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B3015 DISTANCE = 6.29 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A3499 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A2336 NE2 REMARK 620 2 GLU A2338 OE2 91.5 REMARK 620 3 HIS A2466 NE2 92.9 79.8 REMARK 620 4 HOH A3197 O 85.8 94.5 174.1 REMARK 620 5 HOH A3198 O 92.9 175.1 97.8 88.0 REMARK 620 6 HOH A3202 O 166.3 91.7 100.9 80.6 84.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B3499 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B2336 NE2 REMARK 620 2 GLU B2338 OE2 96.5 REMARK 620 3 HIS B2466 NE2 95.8 75.3 REMARK 620 4 HOH B3140 O 68.9 81.5 150.6 REMARK 620 5 HOH B3143 O 155.1 93.1 108.9 90.1 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 3499 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN B 3499 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 3501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 3502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 3503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FYM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF JMJC DOMAIN OF HUMAN HISTONE DEMETHYLASE UTY REMARK 900 IN COMPLEX WITH D-2-HYDROXYGLUTARATE REMARK 900 RELATED ID: 5FYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH D-2-HYDROXYGLUTARATE REMARK 900 RELATED ID: 5FYT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N09996A REMARK 900 RELATED ID: 5FYU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N10042A REMARK 900 RELATED ID: 5FYV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH OXALOACETATE REMARK 900 RELATED ID: 5FYY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N05798A REMARK 900 RELATED ID: 5FYZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N10063A REMARK 900 RELATED ID: 5FZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N11213A REMARK 900 RELATED ID: 5FZ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH E48115B REMARK 900 RELATED ID: 5FZ3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N08776B REMARK 900 RELATED ID: 5FZ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH N10057A REMARK 900 RELATED ID: 5FZ6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT N05859B ( LIGAND MODELLED BASED ON REMARK 900 PANDDA EVENT MAP, SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT ETHYL 2- AMINO-4-THIOPHEN-2- REMARK 900 YLTHIOPHENE-3-CARBOXYLATE (N06131B ) (LIGAND MODELLED BASED ON REMARK 900 PANDDA EVENT MAP, SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZ8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MALATE REMARK 900 RELATED ID: 5FZ9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT THIENO(3,2 -B)THIOPHENE-5- REMARK 900 CARBOXYLIC ACID (N06263B) (LIGAND MODELLED BASED ON PANDDA EVENT REMARK 900 MAP, SGC - DIAMOND I04 -1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH 3D FRAGMENT 2-PIPERIDIN-4- YLOXY-5-(TRIFLUOROMETHYL) REMARK 900 PYRIDINE (N10072A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP) REMARK 900 RELATED ID: 5FZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT 4- PYRIDYLTHIOUREA (N06275B) REMARK 900 (LIGAND MODELLED BASED ON PANDDA EVENT MAP, SGC - DIAMOND I04-1 REMARK 900 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT 4,5- DIHYDRONAPHTHO(1,2-B)THIOPHENE- REMARK 900 2-CARBOXYLICACID (N11181A ) (LIGAND MODELLED BASED ON PANDDA EVENT REMARK 900 MAP, SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH L-2-HYDROXYGLUTARATE REMARK 900 RELATED ID: 5FZE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MC3960 REMARK 900 RELATED ID: 5FZF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MC3962 REMARK 900 RELATED ID: 5FZG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MC3948 REMARK 900 RELATED ID: 5FZH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MAYBRIDGE FRAGMENT 4,5- DIHYDRONAPHTHO(1,2-B)THIOPHENE- REMARK 900 2-CARBOXYLICACID (N11181A ) (LIGAND MODELLED BASED ON PANDDA EVENT REMARK 900 MAP, SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH MC3095 REMARK 900 RELATED ID: 5FZK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH 3D FRAGMENT N,3-DIMETHYL-N -(PYRIDIN-3-YLMETHYL)-1,2- REMARK 900 OXAZOLE-5-CARBOXAMIDE ( N10051A) (LIGAND MODELLED BASED ON PANDDA REMARK 900 EVENT MAP, SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH 3D FRAGMENT 3-METHYL-N- PYRIDIN-4-YL-1,2-OXAZOLE-5- REMARK 900 CARBOXAMIDE (N09954A) ( LIGAND MODELLED BASED ON PANDDA EVENT MAP, REMARK 900 SGC - DIAMOND I04-1 FRAGMENT SCREENING) REMARK 900 RELATED ID: 5FZM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN REMARK 900 COMPLEX WITH 3D FRAGMENT 5-(2-FLUOROPHENYL )-1,3-OXAZOLE-4- REMARK 900 CARBOXYLIC ACID (N09989B) (LIGAND MODELLED BASED ON PANDDA EVENT REMARK 900 MAP, SGC - DIAMOND I04 -1 FRAGMENT SCREENING) REMARK 999 REMARK 999 SEQUENCE REMARK 999 M COME FROM THE EXPRESSION VECTOR. DBREF 5FZO A 2157 2500 UNP Q15652 JHD2C_HUMAN 2157 2500 DBREF 5FZO B 2157 2500 UNP Q15652 JHD2C_HUMAN 2157 2500 SEQADV 5FZO MET A 0 UNP Q15652 EXPRESSION TAG SEQADV 5FZO ALA A 2501 UNP Q15652 EXPRESSION TAG SEQADV 5FZO GLU A 2502 UNP Q15652 EXPRESSION TAG SEQADV 5FZO ASN A 2503 UNP Q15652 EXPRESSION TAG SEQADV 5FZO LEU A 2504 UNP Q15652 EXPRESSION TAG SEQADV 5FZO TYR A 2505 UNP Q15652 EXPRESSION TAG SEQADV 5FZO PHE A 2506 UNP Q15652 EXPRESSION TAG SEQADV 5FZO GLN A 2507 UNP Q15652 EXPRESSION TAG SEQADV 5FZO MET B 0 UNP Q15652 EXPRESSION TAG SEQADV 5FZO ALA B 2501 UNP Q15652 EXPRESSION TAG SEQADV 5FZO GLU B 2502 UNP Q15652 EXPRESSION TAG SEQADV 5FZO ASN B 2503 UNP Q15652 EXPRESSION TAG SEQADV 5FZO LEU B 2504 UNP Q15652 EXPRESSION TAG SEQADV 5FZO TYR B 2505 UNP Q15652 EXPRESSION TAG SEQADV 5FZO PHE B 2506 UNP Q15652 EXPRESSION TAG SEQADV 5FZO GLN B 2507 UNP Q15652 EXPRESSION TAG SEQADV 5FZO ASP B 2340 UNP Q15652 SER 2340 CONFLICT SEQRES 1 A 352 MET ILE PRO HIS SER TRP ILE CYS GLU LYS HIS ILE LEU SEQRES 2 A 352 TRP LEU LYS ASP TYR LYS ASN SER SER ASN TRP LYS LEU SEQRES 3 A 352 PHE LYS GLU CYS TRP LYS GLN GLY GLN PRO ALA VAL VAL SEQRES 4 A 352 SER GLY VAL HIS LYS LYS MET ASN ILE SER LEU TRP LYS SEQRES 5 A 352 ALA GLU SER ILE SER LEU ASP PHE GLY ASP HIS GLN ALA SEQRES 6 A 352 ASP LEU LEU ASN CYS LYS ASP SER ILE ILE SER ASN ALA SEQRES 7 A 352 ASN VAL LYS GLU PHE TRP ASP GLY PHE GLU GLU VAL SER SEQRES 8 A 352 LYS ARG GLN LYS ASN LYS SER GLY GLU THR VAL VAL LEU SEQRES 9 A 352 LYS LEU LYS ASP TRP PRO SER GLY GLU ASP PHE LYS THR SEQRES 10 A 352 MET MET PRO ALA ARG TYR GLU ASP LEU LEU LYS SER LEU SEQRES 11 A 352 PRO LEU PRO GLU TYR CYS ASN PRO GLU GLY LYS PHE ASN SEQRES 12 A 352 LEU ALA SER HIS LEU PRO GLY PHE PHE VAL ARG PRO ASP SEQRES 13 A 352 LEU GLY PRO ARG LEU CSD SER ALA TYR GLY VAL VAL ALA SEQRES 14 A 352 ALA LYS ASP HIS ASP ILE GLY THR THR ASN LEU HIS ILE SEQRES 15 A 352 GLU VAL SER ASP VAL VAL ASN ILE LEU VAL TYR VAL GLY SEQRES 16 A 352 ILE ALA LYS GLY ASN GLY ILE LEU SER LYS ALA GLY ILE SEQRES 17 A 352 LEU LYS LYS PHE GLU GLU GLU ASP LEU ASP ASP ILE LEU SEQRES 18 A 352 ARG LYS ARG LEU LYS ASP SER SER GLU ILE PRO GLY ALA SEQRES 19 A 352 LEU TRP HIS ILE TYR ALA GLY LYS ASP VAL ASP LYS ILE SEQRES 20 A 352 ARG GLU PHE LEU GLN LYS ILE SER LYS GLU GLN GLY LEU SEQRES 21 A 352 GLU VAL LEU PRO GLU HIS ASP PRO ILE ARG ASP GLN SER SEQRES 22 A 352 TRP TYR VAL ASN LYS LYS LEU ARG GLN ARG LEU LEU GLU SEQRES 23 A 352 GLU TYR GLY VAL ARG THR CYS THR LEU ILE GLN PHE LEU SEQRES 24 A 352 GLY ASP ALA ILE VAL LEU PRO ALA GLY ALA LEU HIS GLN SEQRES 25 A 352 VAL GLN ASN PHE HIS SER CYS ILE GLN VAL THR GLU ASP SEQRES 26 A 352 PHE VAL SER PRO GLU HIS LEU VAL GLU SER PHE HIS LEU SEQRES 27 A 352 THR GLN GLU LEU ARG LEU LEU ALA GLU ASN LEU TYR PHE SEQRES 28 A 352 GLN SEQRES 1 B 352 MET ILE PRO HIS SER TRP ILE CYS GLU LYS HIS ILE LEU SEQRES 2 B 352 TRP LEU LYS ASP TYR LYS ASN SER SER ASN TRP LYS LEU SEQRES 3 B 352 PHE LYS GLU CYS TRP LYS GLN GLY GLN PRO ALA VAL VAL SEQRES 4 B 352 SER GLY VAL HIS LYS LYS MET ASN ILE SER LEU TRP LYS SEQRES 5 B 352 ALA GLU SER ILE SER LEU ASP PHE GLY ASP HIS GLN ALA SEQRES 6 B 352 ASP LEU LEU ASN CYS LYS ASP SER ILE ILE SER ASN ALA SEQRES 7 B 352 ASN VAL LYS GLU PHE TRP ASP GLY PHE GLU GLU VAL SER SEQRES 8 B 352 LYS ARG GLN LYS ASN LYS SER GLY GLU THR VAL VAL LEU SEQRES 9 B 352 LYS LEU LYS ASP TRP PRO SER GLY GLU ASP PHE LYS THR SEQRES 10 B 352 MET MET PRO ALA ARG TYR GLU ASP LEU LEU LYS SER LEU SEQRES 11 B 352 PRO LEU PRO GLU TYR CYS ASN PRO GLU GLY LYS PHE ASN SEQRES 12 B 352 LEU ALA SER HIS LEU PRO GLY PHE PHE VAL ARG PRO ASP SEQRES 13 B 352 LEU GLY PRO ARG LEU CSD SER ALA TYR GLY VAL VAL ALA SEQRES 14 B 352 ALA LYS ASP HIS ASP ILE GLY THR THR ASN LEU HIS ILE SEQRES 15 B 352 GLU VAL ASP ASP VAL VAL ASN ILE LEU VAL TYR VAL GLY SEQRES 16 B 352 ILE ALA LYS GLY ASN GLY ILE LEU SER LYS ALA GLY ILE SEQRES 17 B 352 LEU LYS LYS PHE GLU GLU GLU ASP LEU ASP ASP ILE LEU SEQRES 18 B 352 ARG LYS ARG LEU LYS ASP SER SER GLU ILE PRO GLY ALA SEQRES 19 B 352 LEU TRP HIS ILE TYR ALA GLY LYS ASP VAL ASP LYS ILE SEQRES 20 B 352 ARG GLU PHE LEU GLN LYS ILE SER LYS GLU GLN GLY LEU SEQRES 21 B 352 GLU VAL LEU PRO GLU HIS ASP PRO ILE ARG ASP GLN SER SEQRES 22 B 352 TRP TYR VAL ASN LYS LYS LEU ARG GLN ARG LEU LEU GLU SEQRES 23 B 352 GLU TYR GLY VAL ARG THR CYS THR LEU ILE GLN PHE LEU SEQRES 24 B 352 GLY ASP ALA ILE VAL LEU PRO ALA GLY ALA LEU HIS GLN SEQRES 25 B 352 VAL GLN ASN PHE HIS SER CYS ILE GLN VAL THR GLU ASP SEQRES 26 B 352 PHE VAL SER PRO GLU HIS LEU VAL GLU SER PHE HIS LEU SEQRES 27 B 352 THR GLN GLU LEU ARG LEU LEU ALA GLU ASN LEU TYR PHE SEQRES 28 B 352 GLN MODRES 5FZO CSD A 2317 CYS 3-SULFINOALANINE MODRES 5FZO CSD B 2317 CYS 3-SULFINOALANINE HET CSD A2317 16 HET CSD B2317 16 HET MN A3499 1 HET CL A3500 1 HET MN B3499 1 HET CL B3500 1 HET EDO B3501 4 HET EDO B3502 4 HET EDO B3503 4 HETNAM CSD 3-SULFINOALANINE HETNAM MN MANGANESE (II) ION HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 MN 2(MN 2+) FORMUL 4 CL 2(CL 1-) FORMUL 7 EDO 3(C2 H6 O2) FORMUL 10 HOH *502(H2 O) HELIX 1 1 SER A 2177 LYS A 2187 1 11 HELIX 2 2 GLY A 2196 LYS A 2200 5 5 HELIX 3 3 ASN A 2202 TRP A 2206 5 5 HELIX 4 4 LYS A 2207 GLY A 2216 1 10 HELIX 5 5 ASN A 2234 GLU A 2244 1 11 HELIX 6 6 VAL A 2245 ARG A 2248 5 4 HELIX 7 7 GLY A 2267 MET A 2274 1 8 HELIX 8 8 MET A 2274 LEU A 2285 1 12 HELIX 9 9 LEU A 2287 ASN A 2292 1 6 HELIX 10 10 PRO A 2304 VAL A 2308 5 5 HELIX 11 11 SER A 2359 GLU A 2369 1 11 HELIX 12 12 ASP A 2373 ASP A 2382 1 10 HELIX 13 13 ALA A 2395 LYS A 2397 5 3 HELIX 14 14 ASP A 2398 GLN A 2413 1 16 HELIX 15 15 ASP A 2422 GLN A 2427 1 6 HELIX 16 16 ASN A 2432 GLY A 2444 1 13 HELIX 17 17 HIS A 2486 LEU A 2497 1 12 HELIX 18 18 SER B 2177 LYS B 2187 1 11 HELIX 19 19 GLY B 2196 MET B 2201 1 6 HELIX 20 20 ASN B 2202 TRP B 2206 5 5 HELIX 21 21 LYS B 2207 GLY B 2216 1 10 HELIX 22 22 ASN B 2234 GLY B 2241 1 8 HELIX 23 23 VAL B 2245 ARG B 2248 5 4 HELIX 24 24 GLY B 2267 MET B 2274 1 8 HELIX 25 25 MET B 2274 LEU B 2285 1 12 HELIX 26 26 LEU B 2287 ASN B 2292 1 6 HELIX 27 27 PRO B 2304 VAL B 2308 5 5 HELIX 28 28 SER B 2359 GLU B 2369 1 11 HELIX 29 29 ASP B 2373 ASP B 2382 1 10 HELIX 30 30 ALA B 2395 LYS B 2397 5 3 HELIX 31 31 ASP B 2398 GLN B 2413 1 16 HELIX 32 32 ASP B 2422 GLN B 2427 1 6 HELIX 33 33 ASN B 2432 GLY B 2444 1 13 HELIX 34 34 SER B 2483 GLU B 2485 5 3 HELIX 35 35 HIS B 2486 LEU B 2497 1 12 SHEET 1 AA 9 HIS A2159 ILE A2162 0 SHEET 2 AA 9 ILE A2167 LEU A2170 -1 O ILE A2167 N ILE A2162 SHEET 3 AA 9 ALA A2192 VAL A2194 1 O VAL A2193 N LEU A2170 SHEET 4 AA 9 ALA A2457 LEU A2460 -1 O ALA A2457 N VAL A2194 SHEET 5 AA 9 ASP A2341 GLY A2350 -1 O VAL A2342 N LEU A2460 SHEET 6 AA 9 SER A2473 PHE A2481 -1 O SER A2473 N GLY A2350 SHEET 7 AA 9 ARG A2315 ALA A2319 -1 O ARG A2315 N THR A2478 SHEET 8 AA 9 LEU A2259 LEU A2261 -1 O LEU A2261 N SER A2318 SHEET 9 AA 9 LEU A2223 ASN A2224 -1 O LEU A2223 N LYS A2260 SHEET 1 AB 4 THR A2333 ILE A2337 0 SHEET 2 AB 4 LEU A2465 ASN A2470 -1 O HIS A2466 N HIS A2336 SHEET 3 AB 4 PRO A2387 TYR A2394 -1 O LEU A2390 N GLN A2469 SHEET 4 AB 4 CYS A2448 PHE A2453 -1 O CYS A2448 N ILE A2393 SHEET 1 BA 9 HIS B2159 ILE B2162 0 SHEET 2 BA 9 ILE B2167 LEU B2170 -1 O ILE B2167 N ILE B2162 SHEET 3 BA 9 ALA B2192 VAL B2194 1 O VAL B2193 N LEU B2170 SHEET 4 BA 9 ALA B2457 LEU B2460 -1 O ALA B2457 N VAL B2194 SHEET 5 BA 9 ASP B2341 GLY B2350 -1 O VAL B2342 N LEU B2460 SHEET 6 BA 9 SER B2473 PHE B2481 -1 O SER B2473 N GLY B2350 SHEET 7 BA 9 ARG B2315 ALA B2319 -1 O ARG B2315 N THR B2478 SHEET 8 BA 9 LEU B2259 LEU B2261 -1 O LEU B2261 N SER B2318 SHEET 9 BA 9 LEU B2223 ASN B2224 -1 O LEU B2223 N LYS B2260 SHEET 1 BB 4 THR B2333 ILE B2337 0 SHEET 2 BB 4 LEU B2465 ASN B2470 -1 O HIS B2466 N HIS B2336 SHEET 3 BB 4 PRO B2387 TYR B2394 -1 O LEU B2390 N GLN B2469 SHEET 4 BB 4 CYS B2448 PHE B2453 -1 O CYS B2448 N ILE B2393 SSBOND 1 CYS A 2163 CYS A 2448 1555 1555 2.06 SSBOND 2 CYS B 2163 CYS B 2448 1555 1555 2.04 LINK C LEU A2316 N ACSD A2317 1555 1555 1.33 LINK C LEU A2316 N BCSD A2317 1555 1555 1.33 LINK C ACSD A2317 N SER A2318 1555 1555 1.33 LINK C BCSD A2317 N SER A2318 1555 1555 1.33 LINK C LEU B2316 N ACSD B2317 1555 1555 1.33 LINK C LEU B2316 N BCSD B2317 1555 1555 1.33 LINK C ACSD B2317 N SER B2318 1555 1555 1.33 LINK C BCSD B2317 N SER B2318 1555 1555 1.33 LINK NE2 HIS A2336 MN MN A3499 1555 1555 2.23 LINK OE2 GLU A2338 MN MN A3499 1555 1555 2.11 LINK NE2 HIS A2466 MN MN A3499 1555 1555 2.24 LINK O HOH A3197 MN MN A3499 1555 1555 2.31 LINK O HOH A3198 MN MN A3499 1555 1555 2.10 LINK O HOH A3202 MN MN A3499 1555 1555 2.19 LINK NE2 HIS B2336 MN MN B3499 1555 1555 2.62 LINK OE2 GLU B2338 MN MN B3499 1555 1555 2.08 LINK NE2 HIS B2466 MN MN B3499 1555 1555 2.22 LINK O HOH B3140 MN MN B3499 1555 1555 2.48 LINK O HOH B3143 MN MN B3499 1555 1555 2.69 CISPEP 1 TRP A 2264 PRO A 2265 0 -4.83 CISPEP 2 TRP A 2264 PRO A 2265 0 -11.76 CISPEP 3 TRP B 2264 PRO B 2265 0 -6.41 CISPEP 4 GLY B 2313 PRO B 2314 0 2.59 SITE 1 AC1 6 HIS A2336 GLU A2338 HIS A2466 HOH A3197 SITE 2 AC1 6 HOH A3198 HOH A3202 SITE 1 AC2 5 HIS B2336 GLU B2338 HIS B2466 HOH B3140 SITE 2 AC2 5 HOH B3143 SITE 1 AC3 4 MET A2274 PRO A2275 ALA A2276 ARG A2277 SITE 1 AC4 4 MET B2274 PRO B2275 ALA B2276 ARG B2277 SITE 1 AC5 6 LYS B2200 LYS B2283 LEU B2285 PRO B2288 SITE 2 AC5 6 HOH B3113 HOH B3206 SITE 1 AC6 2 TRP B2239 HOH B3086 SITE 1 AC7 5 CSD B2317 THR B2333 HIS B2466 VAL B2468 SITE 2 AC7 5 GLN B2476 CRYST1 45.320 110.920 165.310 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022065 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009016 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006049 0.00000